MK-7454
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-7454, covering 2015-12-15 to 2015-12-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) [Phase 2]